Rubra Medicaments has informed that a meeting of Board of Directors of the Company is scheduled to be held on Friday, March 06, 2020 to approve the shifting of registered office of the Company within the local limits. The Company shall intimate to the exchange the new registered office address upon the conclusion of the Board Meeting as required by SEBI (LODR) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.